ELAVL1 and hepatocellular carcinoma: Along this line, Pearson correlation analyses based on an mRNA array obtained from a cohort of 86 patients with HCC revealed a stronger co-variation between ELAVL1 and the different members of the SUMOylation pathway in the T in contrast to the paired surrounding tissue (ST) (Figures 1F and S1).